BRISTOL MYERS SQUIBB CO Current Liabilities 2008-2026 | BMY
Beta
What is current liabilities?
Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.
What is BRISTOL MYERS SQUIBB CO's current current liabilities?
BRISTOL MYERS SQUIBB CO (BMY) annual current liabilities for 2025 was $23.42B, a 1.50% decline from 2024. BRISTOL MYERS SQUIBB CO current liabilities for the quarter ending March 31, 2026 was $19.16B.
What was BRISTOL MYERS SQUIBB CO's current liabilities in 2024?
BRISTOL MYERS SQUIBB CO annual current liabilities for 2024 was $23.77B, a 6.79% increase from 2023.
What was BRISTOL MYERS SQUIBB CO's current liabilities in 2023?
BRISTOL MYERS SQUIBB CO annual current liabilities for 2023 was $22.26B, a 1.70% increase from 2022.
What is BRISTOL MYERS SQUIBB CO's 5-year current liabilities CAGR?
BRISTOL MYERS SQUIBB CO current liabilities grew at a compound annual growth rate (CAGR) of 4.18% from FY2020 to FY2025, going from $19.08B to $23.42B over 5 years.
Current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+4.2%
FY2020
$19.08B
→
FY2025
$23.42B
080910111213141516171819202122232425
5 years selected
Current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $23.42B | -1.5% | 10-K |
| FY2024 | $23.77B | +6.8% | 10-K |
| FY2023 | $22.26B | +1.7% | 10-K |
| FY2022 | $21.89B | +0.1% | 10-K |
| FY2021 | $21.87B | +14.6% | 10-K |
| FY2020 | $19.08B | +4.2% | 10-K |
| FY2019 | $18.30B | +71.8% | 10-K |
| FY2018 | $10.65B | +11.4% | 10-K |
| FY2017 | $9.56B | +8.2% | 10-K |
| FY2016 | $8.84B | +10.3% | 10-K |
| FY2015 | $8.02B | -5.2% | 10-K |
| FY2014 | $8.46B | -32.0% | 10-K |
| FY2013 | $12.44B | +50.3% | 10-K |
| FY2012 | $8.28B | +6.4% | 10-K |
| FY2011 | $7.78B | +15.4% | 10-K |
| FY2010 | $6.74B | +6.7% | 10-K |
| FY2009 | $6.31B | -5.9% | 10-K |
| FY2008 | $6.71B | - | 10-K |
Company: BRISTOL MYERS SQUIBB COTicker: BMYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →